Drugging the undruggable!
Our research program focuses on reimagining a platform to develop small molecules and/or pair established FDA therapeutics to target critical diseases in human health by bringing molecular modeling and structure-informed machine learning into the genomics era.


EphB1/2 tyrosine kinase signaling in the progression of peripheral neuropathic pain, glioblastoma, and metabolic syndrome.

Malonyl Co-A in the regulation of metabolic reprogramming in cardiometabolic diseases.
Department of Pharmaceutical Sciences, Room 445, 1300 South Coulter Street, Amarillo, Texas 79106, United States
Phone no. 806.414.9706 Email: mahmoudsalama.ahmed@ttuhsc.edu
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.